Readministration of nivolumab for patients with advanced gastric cancer: a case series

Key Points

• Readministration of nivolumab showed promising treatment responses in advanced gastric cancer patients.
• Among the observed cases, two patients experienced significant clinical improvement after retreatment with nivolumab.
• This case series highlights the potential effectiveness of immunotherapy options beyond initial treatments.
• Further exploration is needed to fully understand the long-term effects and optimal timing of nivolumab readministration.